A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

Clinical trial NCT07450599 · RECRUITING

Trial details

NCT number: NCT07450599
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk Localized Prostate Cancer

Start date: 2026-04-27
Primary completion: 2028-10-15
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.